The Board of Directors resolved to the new common share issuance through the increase of capital by capitalization of capital surplus

Published Date:2024-02-29

Original Link:https://www.onenessbio.com/en/news_detail269_4.htm

Statement
No	3	Date of announcement	2024/02/29	Time of announcement	17:05:27
Subject	The Board of Directors resolved to the new common share issuance through the increase of capital by capitalization of capital surplus
To which item it meets	paragraph 11			Date of events	2024/02/29
Date of the board of directors resolution: 2024/02/29 Source of capital increase funds: capital surplus Whether to adopt shelf registration (Yes, please state issuance period/No): No Total monetary value of the issuance and number of shares issued (shares issued not including those distributed to employees if consisting in capital increase from earnings or capital surplus): Total value NT$227,552,610, Total shares 22,755,261 shares If adopting shelf registration, monetary value and number of shares to be issued this time: NA The remaining monetary value and shares after this issuance when adopting shelf registration: NA Par value per share: NT$10 Issue price: NA Number of shares subscribed for by or allocated to employees: NA Number of shares publicly sold: NA Ratio of shares subscribed by or allotted as stock dividends to existing shareholders: For every 1,000 shares, about 50 new shares will be issued. Handling method for fractional shares and shares unsubscripted for by the deadline: Shareholding of less than one share may be grouped by shareholders within 5 days after the book closure date at the Company’s shareholder service agency. Fractions of a share that cannot be grouped into full shares shall be paid in cash and calculated to the amount of one whole NTD (rounded down to the nearest integer). The Chairman is authorized to designate specific persons to purchase the fractional shares at the par value. Rights and obligations of these newly issued shares: Rights and obligations of these newly issued shares are the same as those of the original shares. Utilization of the funds from the capital increase: To increase working capital Any other matters that need to be specified: (1) After the proposal has been passed at the annual general shareholders’ meeting, the annual general shareholders’ meeting shall authorize the board to set a new base date for share allotment and capital increase after submitted to the competent authority for approval. (2) Thereafter, if the number of outstanding shares is affected by the requirements of the competent authorities, or by subjective and objective factors causing necessary adjustments to shareholders’ dividend rates, the annual general shareholders’ meeting shall authorize the board to make such adjustment. The same shall apply for matters not covered herein.